netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

In this section "SPECIALISTS" refer to medical prescribers specialising in Mental Health unless otherwise stated. At Guy's and St Thomas' and Lewisham Hospitals this would refer to SLAM employed consultants

 Details...
04.07.01  Expand sub section  Non-opioid analgesics and compound analgesic preparations
Aspirin tabs
View adult BNF View SPC online
Formulary  
   
Dilofenac sodium tabs, m/r tabs, dispersible tabs, suppositories
View adult BNF View SPC online
Formulary  
Link  MHRA Jun 2013: Diclofenac: new contraindications and warnings
   
Ibuprofen tabs, suspension
View adult BNF View SPC online
Formulary  
Link  MHRA Jun 2015: High-dose ibuprofen (≥2400mg/day): small increase in cardiovascular risk
   
Nefopam tabs
View adult BNF View SPC online
Formulary  
   
Paracetamol injection
View adult BNF View SPC online
Formulary

Restricted to short-term treatment of moderate pain and fever when administration by the intravenous route is clinically justified

For patients weighing less than 50 kg:

  • Max dose = 15 mg/kg
  • Minimum dose interval of 4 hours
  • Maximum daily dose must not exceed 60 mg/kg (without exceeding 3g)

 In severe renal insufficiency (creatinine clearance ≤30 mL/min):

  • Minimum dose interval of 6 hours

Not to exceed 3g as total daily dose in the following patients:

  • Hepatocellular insufficiency
  • Chronic alcoholism
  • Chronic malnutrition or dehydration
 
   
Paracetamol tabs, soluble tabs, oral suspension, suppositories
View adult BNF View SPC online
Formulary  
   
04.07.01  Expand sub section  Compound analgesic preparations
Co-codamol tabs, dispersible tabs (paracetamol and codeine)
View adult BNF View SPC online
Formulary Strengths available:
  • Co-codamol 8/500
  • Co-codamol 30/500 
  •    
    Co-dydramol 10/500 tabs (paracetamol and dihydrocodeine)
    View adult BNF View SPC online
    Formulary  
       
     ....
     Non Formulary Items
    Co-proxamol tabs

    Non Formulary
    Grey

    Not for prescribing in SE London

    Link  SE London APC: Patient Information Leaflet: Changes to co-proxamol prescribing
    Link  Unlicensed Co-proxamol (dextropropoxyphene and paracetamol) Prescribing Factsheet
     
    Tramadol with paracetamol combination preparations  (Tramacet)

    View adult BNF View SPC online
    Non Formulary
    Grey

    Not approved for use in SE London

    Link  SE London Position Statement: Paracetamol and tramadol combination products for pain
     
      
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Red

    Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

    Amber 1

    Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

    Amber 2

    Specialist initiation followed by maintenance prescribing in primary care  

    Amber 3

    Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

    Green

    Specialist and non-specialist initiation  

    Grey

    Not recommended for prescribing  

    netFormulary